# Passage Bio, Inc. (PASG)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PASG/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -15.38M | $ -22.17M | $ 0 | $ 4.46M |
| 2025 | $ 0 | $ -46.61M | $ -32.26M | $ 24.01M | $ 18.76M |
| 2024 | $ 0 | $ -68.08M | $ -50.44M | $ 25.48M | $ 61.26M |
| 2023 | $ 0 | $ -110.35M | $ -84.78M | $ 26.29M | $ 111.28M |
| 2022 | $ 0 | $ -152.07M | $ -139.62M | $ 27.11M | $ 201.37M |
| 2021 | $ 0 | $ -220.36M | $ -181.29M | $ 0 | $ 318.66M |
| 2020 | $ 0 | $ -142.98M | $ -104.67M | $ 0 | $ 304.71M |
| 2019 | $ 0 | $ -58.90M | $ -53.68M | $ 0 | $ 174.35M |
| 2018 | $ 0 | $ -7.69M | $ -24.6K | $ 0 | $ 30.95M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 4.65 |
| Current Ratio | 1.22 |

## Other views

- [Metrics](https://sponda.capital/en/PASG.md)
- [Charts](https://sponda.capital/en/PASG/charts.md)
- [Compare](https://sponda.capital/en/PASG/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.